Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of 2-(furan-2-ylmethylene)hydrazine-1-carbothioamide derivatives as novel inhibitors of SARS-CoV-2 main protease
Xiaodong Dou, Qi Sun, Guofeng Xu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114508-114508
Open Access | Times Cited: 10

Showing 10 citing articles:

The research progress of SARS-CoV-2 main protease inhibitors from 2020 to 2022
Xiaojing Pang, Wei Xu, Yang Liu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115491-115491
Open Access | Times Cited: 64
Recent breakthroughs in synthetic small molecules targeting SARS-CoV-2 Mpro from 2022 to 2024
Laura Braconi, Alice Sosic, Letizia Crocetti
Bioorganic & Medicinal Chemistry (2025), pp. 118247-118247
Closed Access
Attention Mechanism-Based Graph Neural Network Model for Effective Activity Prediction of SARS-CoV-2 Main Protease Inhibitors: Application to Drug Repurposing as Potential COVID-19 Therapy
Yanling Wu, Kun Li, Menglong Li, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 22, pp. 7011-7031
Closed Access | Times Cited: 4
Discovery of novel and selective farnesoid X receptor antagonists through structure-based virtual screening, preliminary structure-activity relationship study, and biological evaluation
Xiaodong Dou, Tongyu Huo, Yameng Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116323-116323
Closed Access | Times Cited: 1
Synthesis and Virtual Screening of Pyrazolothiazole Conjugates as Promising SARS‐CoV‐2 Inhibitors
Amal F. Seliem
ChemistrySelect (2023) Vol. 8, Iss. 19
Closed Access | Times Cited: 3
Discovery of anti-SARS-CoV-2 agents from commercially available flavor <i>via</i> docking screening
Jiaojiao Zhang, Xin Shen, Yanpeng Li, et al.
Medicinal Plant Biology (2023) Vol. 2, Iss. 1
Open Access | Times Cited: 1
Synthesis of New N-[β-(Hetero)arylethyl]benzimidazole-2-carbothioamides and Their Analogues as Anti-Infective Agents and Compounds with Possible Neuro(psycho)tropic and Anticancer activity
Л. Н. Диваева, А. А. Зубенко, А. С. Морковник, et al.
Russian Journal of General Chemistry (2024) Vol. 94, Iss. 2, pp. 341-351
Closed Access
Alkylation Reaction of Functionally Substituted 2-Hydrazine-1-carbothioamides with Some Unsaturated and Aryl Halides and Biological Activity of the Synthesized Compounds
K. S. Avetisyan, L. Kh. Galstyan
Russian Journal of General Chemistry (2024) Vol. 94, Iss. 11, pp. 2883-2888
Closed Access
X-ray Structures and Computational Studies of Two Bioactive 2-(Adamantane-1-carbonyl)-N-substituted Hydrazine-1-carbothioamides
Lamya H. Al-Wahaibi, Kowsalya Alagappan, Olivier Blacque, et al.
Molecules (2022) Vol. 27, Iss. 23, pp. 8425-8425
Open Access | Times Cited: 2
Discovery of 3-oxo-1,2,3,4-tetrahydropyrido[1,2-a]pyrazin derivatives as SARS-CoV-2 main protease inhibitors through virtual screening and biological evaluation
Xiaodong Dou, Qi Sun, Yameng Liu, et al.
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 97, pp. 129547-129547
Closed Access
Five-membered ring systems: furans and benzofurans
Halina Kwiecień
Progress in heterocyclic chemistry (2023), pp. 251-280
Closed Access
Page 1

Scroll to top